brexanolone — FDA meeting
Q3 2026
We have requested a guidance meeting with the FDA and the meeting is scheduled for the third quarter of 2026.Source filing
LPCN biotech catalysts & pipeline
LIPOCINE INC · Data as of 2026-09-08
Upcoming catalysts
testosterone undecanoate — Regulatory decision
2027
The deferred revenue is expected to be recognized as revenue within 60 days of SPC's receipt of marketing authorization for TLANDO in South Korea (the "SPC Territory"), which is expected to occur in 2027.Source filing